Typical Dosing and Administration Protocols

The available literature provides limited specific dosing information for bioidentical progesterone protocols. Based on the evidence reviewed, here are general patterns reported:

Menopausal Hormone Therapy

Micronized progesterone is commonly used as part of combination hormone replacement therapy regimens
Protocols typically involve cyclic or continuous administration depending on the specific therapeutic approach
Dosing appears to be individualized based on patient factors and treatment goals

Administration Routes

The literature mentions various compounded formulations of bioidentical progesterone, though specific dosing details are not provided in the available evidence.

Clinical Context

Studies indicate that progesterone is often used in combination with estradiol as part of comprehensive hormone replacement therapy protocols, particularly in menopausal women.

Evidence Limitations

Important note: The available evidence does not provide detailed, specific dosing protocols for bioidentical progesterone. Most studies focus on general patterns of hormone therapy use or comparative effectiveness rather than precise dosing guidelines. Several relevant clinical trials were terminated or have unknown status, limiting the available data on standardized protocols.

Medical Disclaimer: This information is for educational purposes only and does not constitute personalized medical advice. Hormone therapy protocols should always be determined by qualified healthcare providers based on individual patient assessment, medical history, and current clinical guidelines. Dosing, administration routes, and treatment duration must be individualized and monitored by healthcare professionals.

Progesterone (Bioidentical)

Member access required